Résumé
Les auto-anticorps (AAC), aussi nommés anticorps naturels, sont des anticorps présents dans la circulation d’individus sains, et qui sont produits en l’absence d’une stimulation antigénique spécifique [1]. Découverts à la fin des années 1980 par le groupe d’Avrameas [2, 3], les AAC correspondent aux immunoglobulines (Ig).
Preview
Unable to display preview. Download preview PDF.
Références
Coutinho A (1995) Immune or autoimmune? Clin Exp Immunol 101 Suppl 1: 3–5
Dighiero G, Lymberi P, Guilbert B, et al. (1986) Natural autoantibodies constitute a substantial part of normal circulating immunoglobulins. Ann N Y Acad Sci 475: 135–45
Avrameas S (1991) Natural autoantibodies: from ”horror autotoxicus“ to ”gnothi seauton“. Immunol Today 12: 154–9
Berneman A, Ternynck T, Avrameas S (1992) Natural mouse IgG reacts with self antigens including molecules involved in the immune response. Eur J Immunol 22: 625–33
Grandien A, Coutinho A, Andersson J, et al. (1991) Endogenous VH gene family expression in immunoglobulin-transgenic mice: evidence for selection of antibody repertoires. Int Immunol 3: 67–73
Avrameas S, Ternynck T (1993) The natural autoantibodies system: between hypotheses and facts. Mol Immunol 30: 1133–42
Zelenay S, Moraes Fontes MF, Fesel C, et al. (2007) Physiopathology of natural auto-antibodies: the case for regulation. J Autoimmun 29: 229–35
Coutinho A, Kazatchkine MD, Avrameas S (1995) Natural autoantibodies. Curr Opin Immunol 7: 812–8
Adib M, Ragimbeau J, Avrameas S, et al. (1990) IgG autoantibody activity in normal mouse serum is controlled by IgM. J Immunol 145: 3807–13
Shlomchik MJ, Aucoin AH, Pisetsky DS, et al. (1987) Structure and function of anti-DNA autoantibodies derived from a single autoimmune mouse. Proc Natl Acad Sci USA 84: 9150–4
Coutinho A, Avrameas S (1992) Speculations on immunosomatics: potential diagnostic and therapeutic value of immune homeostasis concepts. Scand J Immunol 36: 527–32
Ando K, Kikugawa K, Beppu M (1994) Involvement of sialylated poly-N-acetyllactosaminyl sugar chains of band 3 glycoprotein on senescent erythrocytes in anti-band 3 autoantibody binding. J Biol Chem 269: 19394–8
Schlesinger LS, Horwitz MA (1994) A role for natural antibody in the pathogenesis of leprosy: antibody in nonimmune serum mediates C3 fixation to the Mycobacterium leprae surface and hence phagocytosis by human mononuclear phagocytes. Infect Immun 62: 280–9
Shlomchik MJ, Marshak-Rothstein A, Wolfowicz CB, et al. (1987) The role of clonal selection and somatic mutation in autoimmunity. Nature 328: 805–11
Bendtzen K, Hansen MB, Ross C, et al. (1996) Cytokine autoantibodies. In: J. B. Peter and Y. Shoenfeld (ed) Autoantibodies, Amsterdam, p 260–16
Antonelli G (1997) In vivo development of antibody to interferons: an update to 1996. J Interferon Cytokine Res 17 Suppl 1: S39–46
Jouvenne P, Fossiez F, Banchereau J, et al. (1997) High levels of neutralizing autoantibodies against IL-1 alpha are associated with a better prognosis in chronic polyarthritis: a follow-up study. Scand J Immunol 46: 413–8
Rapoport SI (1976) Blood-Brain Barrier in Physiology and Medicine. Raven Press, New York
Ritchie TC, Fabian RH, Choate JV, et al. (1986) Axonal transport of monoclonal antibodies. J Neurosci 6: 1177–84
Ritchie TC, Fabian RH, Coulter JD (1985) Axonal transport of antibodies to subcellular and protein fractions of rat brain. Brain Res 343: 252–61
Adamson P, Wilbourn B, Etienne-Manneville S, et al. (2002) Lymphocyte trafficking through the blood-brain barrier is dependent on endothelial cell heterotrimeric G-protein signaling. FASEB J 16: 1185–94
Klein R, Bansch M, Berg PA (1992) Clinical relevance of antibodies against serotonin and gangliosides in patients with primary fibromyalgia syndrome. Psychoneuroendocrinology 17: 593–8
Tanaka S, Matsunaga H, Kimura M, et al. (2003) Autoantibodies against four kinds of neurotransmitter receptors in psychiatric disorders. J Neuroimmunol 141: 155–64
Schott K, Schaefer JE, Richartz E, et al. (2003) Autoantibodies to serotonin in serum of patients with psychiatric disorders. Psychiatry Res 121: 51–7
Fetissov SO, Hallman J, Oreland L, et al. (2002) Autoantibodies against alfa-MSH, ACTH and LHRH in anorexia and bulimia nervosa patients. Proc Nat Acad Sci 99: 17155–60
Fetissov SO, Harro J, Jaanisk M, et al. (2005) Autoantibodies against neuropeptides are associated with psychological traits in eating disorders. Proc Natl Acad Sci USA 102: 14865–70
Sinno MH, Do Rego JC, Coeffier M, et al. (2009) Regulation of feeding and anxiety by alpha-MSH reactive autoantibodies. Psychoneuroendocrinology 34: 140–9
Fetissov SO, Dechelotte P (2008) The putative role of neuropeptide autoantibodies in anorexia nervosa. Curr Opin Clin Nutr Metab Care 11: 428–34
Fetissov SO, Hamze Sinno M, Coeffier M, et al. (2008) Autoantibodies against appetite-regulating peptide hormones and neuropeptides: putative modulation by gut microflora. Nutrition 24: 348–59
Fetissov SO, Hamze Sinno M, Coquerel Q, et al. (2008) Emerging role of autoantibodies against appetite-regulating neuropeptides in eating disorders. Nutrition 24: 854–9
Blazer DG (2000) Mood disorders: epidemiology. In: B. J. Sadock and V. A. Sadock (ed) Comprehensive Textbook of Psychiatry, New York, p 1298–308
Zorrilla EP, Luborsky L, McKay JR, et al. (2001) The relationship of depression and stressors to immunological assays: a meta-analytic review. Brain Behav Immun 15: 199–226
Dunn AJ, Swiergiel AH, de Beaurepaire R (2005) Cytokines as mediators of depression: what can we learn from animal studies? Neurosci Biobehav Rev 29: 891–909
Schleifer SJ, Keller SE, Bond RN, et al. (1989) Major depressive disorder and immunity. Role of age, sex, severity, and hospitalization. Arch Gen Psychiatry 46: 81–7
Anisman H, Ravindran AV, Griffiths J, et al. (1999) Interleukin-1 beta production in dysthymia before and after pharmacotherapy. Biol Psychiatry 46: 1649–55
Roy BF, Rose JW, McFarland HF, et al. (1986) Anti-beta-endorphin immunoglobulin G in Humans. Proc Nat Acad Sci 83: 8793–4
Roy BF, Rose JW, Sunderland T, et al. (1988) Antisomatostatin IgG in major depressive disorder: a preliminary study with implications for an autoimmune mechanism of depression. Arch Gen Psychiatry 45: 924–8
Maes M, Delange J, Ranjan R, et al. (1997) Acute phase proteins in schizophrenia, mania and major depression: modulation by psychotropic drugs. Psychiatry Res 66: 1–11
Nunes SO, Reiche EM, Morimoto HK, et al. (2002) Immune and hormonal activity in adults suffering from depression. Braz J Med Biol Res 35: 581–7
Song C, Dinan T, Leonard BE (1994) Changes in immunoglobulin, complement and acute phase protein levels in the depressed patients and normal controls. J Affect Disord 30: 283–8
Legros S, Mendlewicz J, Wybran J (1985) Immunoglobulins, autoantibodies and other serum protein fractions in psychiatric disorders. Eur Arch Psychiatry Neurol Sci 235: 9–11
Garcia FD, Coquerel Q, do Rego JC, et al. (2012) Anti-neuropeptide Y plasma immunoglobulins in relation to mood and appetite in depressive disorder. Psychoneuroendocrinology 37: 1457–67
Garcia FD, Coquerel Q, Kiive E, et al. (2011) Autoantibodies reacting with vasopressin and oxytocin in relation to cortisol secretion in mild and moderate depression. Prog Neuropsychopharmacol Biol Psychiatry 35: 118–25
Joyce PR, Hawes CR, Mulder RT, et al. (1992) Elevated levels of acute phase plasma proteins in major depression. Biol Psychiatry 32: 1035–41
Van Hunsel F, Wauters A, Vandoolaeghe E, et al. (1996) Lower total serum protein, albumin, and beta-and gamma-globulin in major and treatmentresistant depression: effects of antidepressant treatments. Psychiatry Res 65: 159–69
Bauer J, Hohagen F, Gimmel E, et al. (1995) Induction of cytokine synthesis and fever suppresses REM sleep and improves mood in patients with major depression. Biol Psychiatry 38: 611–21
Herbert TB, Cohen S (1993) Depression and immunity: a meta-analytic review. Psychol Bull 113: 472–86
52 Schiepers OJ, Wichers MC, Maes M (2005) Cytokines and major depression. Prog Neuropsychopharmacol Biol Psychiatry 29: 201–17
Fetissov SO, Hallman J, Nilsson I, et al. (2006) Aggressive behavior linked to corticotropin-reactive autoantibodies. Biol Psychiatry 60: 799–802
Karaiskos D, Mavragani CP, Sinno MH, et al. (2010) Psychopathological and personality features in primary Sjogren’s syndrome—associations with autoantibodies to neuropeptides. Rheumatology 49(9): 1762–9
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Copyright information
© 2014 Springer-Verlag France, Paris
About this chapter
Cite this chapter
Garcia, F.D. (2014). Apport de la neuro-immunologie en psychiatrie. In: Apport des neurosciences à la psychiatrie clinique. Springer, Paris. https://doi.org/10.1007/978-2-8178-0505-4_5
Download citation
DOI: https://doi.org/10.1007/978-2-8178-0505-4_5
Publisher Name: Springer, Paris
Print ISBN: 978-2-8178-0504-7
Online ISBN: 978-2-8178-0505-4
eBook Packages: MedicineMedicine (R0)